A Phase 2b Study of Modified Vaccinia Virus to Treat Advanced Liver Cancer (TRAVERSE)
Sponsor and Collaborators
Jennerex Biotherapeutics
Contact
Caro Unger
patientinquiry@jennerex.com
Investigator
David Kirn, MD
Continue Reading
ClinicalTrials.gov Identifier
NCT01387555